print small large

This application is a service of the Singapore Government.

Health Sciences Authority

Chinese Proprietary Medicines

complementary_health_product

Having recognised the role of traditional Chinese medicine in the local context, HSA has taken steps to regulate products and practices in this area. HSA's Chinese Proprietary Medicines (CPM) Unit was set up in 1996 to administer regulatory control on CPM, with the following aims:

  • To ensure that CPM sold in Singapore are safe and of good quality;
  • To ensure that CPM are labelled appropriately; and
  • To facilitate prompt withdrawal of CPM from the market when necessary.

鉴于中药作为辅助药物在本地保健体系中所处的地位,卫生科学局已采取步骤对中药的产品和经营进行管理。中成药处于1996年成立,负责本地中成药的管理。管理的目的是要确保:

  • 在新加坡上市的中成药的安全和品质
  • 中成药的标签符合要求
  • 在必要时可迅速地将药品从市场上回收。

For more information on what is considered as a CPM and the regulatory controls in Singapore, please refer to this page.

欲知更多详情,请查阅此网页